BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21150611)

  • 1. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.
    Du Clos TW; Mold C
    Curr Opin Organ Transplant; 2011 Feb; 16(1):15-20. PubMed ID: 21150611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural recognition and functional activation of FcgammaR by innate pentraxins.
    Lu J; Marnell LL; Marjon KD; Mold C; Du Clos TW; Sun PD
    Nature; 2008 Dec; 456(7224):989-92. PubMed ID: 19011614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxins and Fc receptors.
    Lu J; Marjon KD; Mold C; Du Clos TW; Sun PD
    Immunol Rev; 2012 Nov; 250(1):230-8. PubMed ID: 23046133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Complement System by Pentraxins.
    Haapasalo K; Meri S
    Front Immunol; 2019; 10():1750. PubMed ID: 31428091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern recognition by pentraxins.
    Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A
    Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxins in Complement Activation and Regulation.
    Ma YJ; Garred P
    Front Immunol; 2018; 9():3046. PubMed ID: 30619374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors.
    Mold C; Baca R; Du Clos TW
    J Autoimmun; 2002 Nov; 19(3):147-54. PubMed ID: 12419285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTX3 as a paradigm for the interaction of pentraxins with the complement system.
    Inforzato A; Doni A; Barajon I; Leone R; Garlanda C; Bottazzi B; Mantovani A
    Semin Immunol; 2013 Feb; 25(1):79-85. PubMed ID: 23747040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxins and Fc Receptor-Mediated Immune Responses.
    Lu J; Mold C; Du Clos TW; Sun PD
    Front Immunol; 2018; 9():2607. PubMed ID: 30483265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3.
    Lech M; Rommele C; Anders HJ
    Nephrol Dial Transplant; 2013 Apr; 28(4):803-11. PubMed ID: 23243042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological actions of pentraxins.
    Vilahur G; Badimon L
    Vascul Pharmacol; 2015 Oct; 73():38-44. PubMed ID: 25962566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
    J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice.
    Cox N; Pilling D; Gomer RH
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8385-90. PubMed ID: 26106150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxins in invertebrates and vertebrates: From structure, function and evolution to clinical applications.
    Wang Y; Chen W; Ding S; Wang W; Wang C
    Dev Comp Immunol; 2023 Dec; 149():105064. PubMed ID: 37734429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system.
    Ma YJ; Doni A; Skjoedt MO; Honoré C; Arendrup M; Mantovani A; Garred P
    J Biol Chem; 2011 Feb; 286(5):3405-17. PubMed ID: 21106539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to
    Parente R; Possetti V; Erreni M; D'Autilia F; Bottazzi B; Garlanda C; Mantovani A; Inforzato A; Doni A
    Front Immunol; 2021; 12():785883. PubMed ID: 34868070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens.
    Du Clos TW
    Mol Biol Rep; 1996; 23(3-4):253-60. PubMed ID: 9112237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
    Brilland B; Vinatier E; Subra JF; Jeannin P; Augusto JF; Delneste Y
    Front Immunol; 2020; 11():626343. PubMed ID: 33664737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxins, humoral innate immunity and tissue injury.
    Manfredi AA; Rovere-Querini P; Bottazzi B; Garlanda C; Mantovani A
    Curr Opin Immunol; 2008 Oct; 20(5):538-44. PubMed ID: 18579363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs.
    Mold C; Gresham HD; Du Clos TW
    J Immunol; 2001 Jan; 166(2):1200-5. PubMed ID: 11145702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.